Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.4 SEK | -4.27% | -0.98% | +60.32% |
Jun. 28 | Magle Chemoswed Finalizes Agreement for pK Chemicals, pK Biotech Acquisition | MT |
Jun. 17 | Magle Chemoswed Holding AB Announces Increasing Production Capacity | CI |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 289.4 | 272.2 | 436.3 | - | - |
Enterprise Value (EV) 1 | 289.4 | 317.6 | 489.7 | 478.3 | 462.3 |
P/E ratio | 30.8 x | 22.3 x | 21.3 x | 13.9 x | 11.9 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | 1.6 x | 2.36 x | 2.02 x | 1.86 x |
EV / Revenue | - | 1.86 x | 2.65 x | 2.22 x | 1.97 x |
EV / EBITDA | - | 10.2 x | 11.3 x | 8.54 x | 7.12 x |
EV / FCF | - | -108,204,770 x | - | - | - |
FCF Yield | - | -0% | - | - | - |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 10,800 | 10,800 | 10,800 | - | - |
Reference price 2 | 26.80 | 25.20 | 40.40 | 40.40 | 40.40 |
Announcement Date | 2/16/23 | 2/16/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | 170.4 | 184.8 | 215.5 | 234.8 |
EBITDA 1 | - | 31.11 | 43.4 | 56 | 64.9 |
EBIT 1 | - | 18.01 | 28.8 | 38.8 | 46.1 |
Operating Margin | - | 10.57% | 15.58% | 18% | 19.63% |
Earnings before Tax (EBT) | - | 15.08 | - | - | - |
Net income 1 | 9.409 | 12.17 | 21 | 30.8 | 36.6 |
Net margin | - | 7.14% | 11.36% | 14.29% | 15.59% |
EPS 2 | 0.8700 | 1.130 | 1.900 | 2.900 | 3.400 |
Free Cash Flow | - | -2.935 | - | - | - |
FCF margin | - | -1.72% | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 2/16/23 | 2/16/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q1 | 2023 Q2 | 2023 Q4 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|
Net sales 1 | 38.65 | 38.07 | 57.37 | 43.6 | 49.5 | 53.5 |
EBITDA 1 | - | 9.5 | 9.291 | 13.6 | 11.8 | 11 |
EBIT 1 | - | 6.266 | 5.897 | 10.1 | 7.8 | 6.7 |
Operating Margin | - | 16.46% | 10.28% | 23.17% | 15.76% | 12.52% |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income | 2.884 | - | - | - | - | - |
Net margin | 7.46% | - | - | - | - | - |
EPS 2 | - | 0.4300 | - | 0.7000 | 0.5000 | 0.4000 |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/19/23 | 7/18/23 | 2/16/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | - | 45.4 | 53.4 | 42 | 26 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 1.46 x | 1.23 x | 0.75 x | 0.4006 x |
Free Cash Flow | - | -2.94 | - | - | - |
ROE (net income / shareholders' equity) | - | 9.5% | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | - | 15.1 | - | - | - |
Capex / Sales | - | 8.87% | - | - | - |
Announcement Date | 2/16/23 | 2/16/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.32% | 41.43M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- MAGLE Stock
- Financials Magle Chemoswed Holding AB